nitric oxide system is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-05-13. Numbers and descriptions here follow the published literature rather than marketing material.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Assessed by visual inspection under ordinary laboratory lighting |
| Molecular mass | Approximately 1419 Da | Monoisotopic mass for the fifteen-residue sequence |
| Solubility class | Freely soluble in water | Stock solutions commonly prepared in water or aqueous buffer |
| Typical storage temperature | -20 °C or below, desiccated | Lyophilized powder; repeated freeze-thaw cycles are usually avoided |
| Common analytical method | Reversed-phase HPLC with UV detection | Frequently paired with mass spectrometry to confirm identity |
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
=== Brand names === It is marketed under the brand name Rivotril by Roche in Argentina, Australia, Austria, Bangladesh, Belgium, Brazil, Canada, Colombia, Costa Rica, Croatia, the Czech Republic, Denmark, Estonia, Germany, Hungary, Iceland, Ireland, Italy, China, Mexico, the Netherlands, Norway, Portugal, Peru, Pakistan, Romania, Serbia, South Africa, South Korea, Saudi Arabia, Spain, Turkey, and the United States; Emcloz, Linotril, Lonazep, Clotrin and Clonotril in India and other parts of Europe; under the name Riklona in Indonesia and Malaysia; and under the brand name Klonopin by Roche in the United States. Other names, such as Antelepsin, Clonoten, Ravotril, Rivotril, Iktorivil, Clonex (Israel), Paxam, Petril, Naze, Zilepam and Kriadex, are used throughout the world. In August 2021, Roche Australia transferred Rivotril to Pharmaco Australia Ltd.
=== Synthetic analogues === Many vitamin B1 analogues, such as Benfotiamine, fursultiamine, and sulbutiamine, are synthetic derivatives of thiamine. Most were developed in Japan in the 1950s and 1960s as forms that were intended to improve absorption compared to thiamine. Some are approved for use in some countries as a drug or non-prescription dietary supplement for treatment of diabetic neuropathy or other health conditions.
"I believe that all the power of the supreme being is not enough to liberate that despicable country (Peru): only Bolívar, supported by force, can do it." It is also known that San Martín wanted the disputed territory of Upper Peru, administered since 1810 by the Viceroyalty of Peru, to be handed over to the United Provinces of the Río de la Plata, which, although it would be somewhat predictable on his part (because it was an Argentine) in the exercise of a realpolitik, on the other hand it would be a sign of anti-Peruvianism on his part in the face of vague promises that he made to warlords, like Andrés de Santa Cruz, over the territory. Given this, he was allegedly accused of being dishonest with his ambiguous promises that he gave to Peruvian politicians who supported his government, since the Protectorate of San Martín de facto controlled the Atacama Party and was also claiming part of the territories of the current La Paz and Pando. That ended up generating a climate of mistrust, where the praises and praise of the Peruvians to the Liberator would have been apparent, in the midst of hostilities towards the Argentine caudillo. In the secret session of the Peruvian Congress, on September 27, 1822, suspicion and fear were expressed that San Martín tried to seize the provinces of Upper Peru, Arequipa and Cuzco.
=== Burns === The Healing Foundation facilitated the establishment of two research centres dedicated to burns. The first, situated at Frenchay Hospital in Bristol, aimed to develop innovative techniques for burn prevention and enhance clinical care for affected children. The Centre for Children's Burns Research was officially opened in June 2013 by Sophie, Duchess of Edinburgh. Subsequently, another research hub, the Healing Foundation Centre for Burns Research, was inaugurated at Queen Elizabeth Hospital in Birmingham in October 2013. A notable outcome of The Healing Foundation Centre for Children's Burns Research was the SmartWound PREDICT Dressing, developed by scientists at the University of Bath. This dressing changes colour upon detecting bacteria, providing an alternative method for infection detection.
Sources: en.wikipedia.org
13 December Mark Drakeford resigns as First minister of Wales after five years in incumbent. Bernard Looney, the former chief executive of BP, is to forfeit up to £32.4m in salary and benefits after an investigation found he committed "serious misconduct" in failing to disclose relationships with colleagues. 14 December The Bank of England keeps interest rates on hold for a third consecutive time at 5.25%. 17-year-old Alex Batty, a boy from Oldham who went missing in 2017 while on holiday in Spain, is reported by French Police to have been found at Revel, a town east of Toulouse in France. Three men are convicted of attempted murder after two children (including an 11-year-old girl) were shot while playing on a climbing frame, in Wolverhampton. Panini Group launches the first sticker album for the Women's Super League. 15 December The High Court rules that Prince Harry was the victim of phone hacking by Mirror Group Newspapers and awards him £140,600 in damages. Separately, the judge rules that Piers Morgan knew about phone hacking – and was involved – while editor of the Daily Mirror. Muslim convert Edward Little, who planned to kill a Christian preacher at Speaker's Corner in London's Hyde Park, is sentenced to life imprisonment with a minimum term of 16 years following a trial at the Old Bailey. Network Rail regional manager Michelle Handforth resigns from her post following a power outage at Ladbroke Grove earlier in the month which left hundreds of train passengers stranded for several hours.
Despite never having attended college – or any formal schooling beyond high school – Rathbun had authored more than 80 scientific publications, described over 674 new species of crustacean, and developed a system for crustacean-related records at the Smithsonian Museum. 1917: Dutch biologist and phytopathologist Johanna Westerdijk became the first female university professor in the Netherlands. She was appointed an extraordinary professor of phytopathology at the University of Utrecht. 1918: German physicist and mathematician Emmy Noether created Noether's theorem explaining the connection between symmetry and conservation laws. 1919: Dutch biologist and geneticist Jantina Tammes became the university professor in the Netherlands. She was appointed an extraordinary professor of variability and heredity at the University of Groningen. She became the first person in the Netherlands to occupy a chair in genetic. Moreover, she became the second female professor in the country, and the first one at the University of Groningen. She held this position until 1937, when she resigned at the age of sixty-six. 1919: Chilean engineer Justicia Espada Acuña graduates from Universidad de Chile, becoming the first woman with degree in civil engineering in South America 1919: Kathleen Maisey Curtis became the first New Zealand woman to earn a Doctorate of Science degree (DSc), completing her thesis on Synchytrium endobioticum (potato wart disease) at the Imperial College of Science and Technology.
Damage caused by the storm includes at Castle Douglas High School where the roof of the building was partially blown off. Coastguard searching for a commercial scallop diver, missing in Scapa Flow, Orkney since 27 November, find a body. A 19-year-old man is killed, and three other people injured, in a crash on the outskirts of Inverurie, Aberdeenshire. A 41-year-old woman, subsequently named as Michelle McLeod, is killed in a dog attack at a flat in Aberdeen. 8 December – Police Scotland confirm human remains have been found in the wreckage of a plane discovered in the North Sea, near Lerwick, Shetland. Scottish Labour suspends Cammy Day, the leader of Edinburgh City Council, pending the outcome of a police investigation into alleged inappropriate behaviour. 9 December – Cammy Day confirms he has stepped down as leader of Edinburgh City Council after Police Scotland launched an investigation into allegations he bombarded Ukrainian refugees with questions, including those of a sexual nature. BBC Scotland announces the launch of two new news programmes in early 2025: Reporting Scotland: News at Seven, a weeknight news bulletin presented by Laura Maciver and Amy Irons on the BBC Scotland channel from 6 January, and the Scotcast podcast with Martin Geissler launching on 13 January. 10 December – A Scottish Government spokesman confirms that First Minister John Swinney has spoken by phone with US President-elect Donald Trump for the first time since his re-election, and described the 20 minute discussion as "positive".
Gene defects in the leptin gene (ob) are rare in human obesity. As of July 2010, only 14 individuals from five families have been identified worldwide who carry a mutated ob gene (one of which was the first ever identified cause of genetic obesity in humans)—two families of Pakistani origin living in the UK, one family living in Turkey, one in Egypt, and one in Austria—and two other families have been found that carry a mutated ob receptor. Others have been identified as genetically partially deficient in leptin, and, in these individuals, leptin levels on the low end of the normal range can predict obesity. Several mutations of genes involving the melanocortins (used in brain signaling associated with appetite) and their receptors have also been identified as causing obesity in a larger portion of the population than leptin mutations.
The use of cationic micelles of cetrimonium chloride, benzethonium chloride, and cetylpyridinium chloride can accelerate chemical reactions between negatively charged compounds (such as DNA or Coenzyme A) in an aqueous environment up to 5 million times. Unlike conventional micellar catalysis, the reactions occur solely on the charged micelles' surface. Micelle formation is essential for the absorption of fat-soluble vitamins and complicated lipids within the human body. Bile salts formed in the liver and secreted by the gall bladder allow micelles of fatty acids to form. This allows the absorption of complicated lipids (e.g., lecithin) and lipid-soluble vitamins (A, D, E, and K) within the micelle by the small intestine. During the process of milk-clotting, proteases act on the soluble portion of caseins, κ-casein, thus originating an unstable micellar state that results in clot formation. Micelles can also be used for targeted drug delivery as gold nanoparticles.
Sources: en.wikipedia.org
In 2020, Chen Xiaojiang was appointed as head of the National Ethnic Affairs Commission, the first Han Chinese head of the body since 1954. On 24 June 2022, Pan Yue, another Han Chinese, became the head of the commission, with him reportedly holding assimilationist policies toward ethnic minorities. Xi outlined his official views relations between the majority Han Chinese and ethnic minorities by saying "[n]either Han chauvinism nor local ethnic chauvinism is conducive to the development of a community for the Chinese nation." Xi's policies toward ethnic minorities were codified in the Law on Promoting Ethnic Unity and Progress in 2026.
=== Constellation === Natera offers a cloud-based bioinformatics platform called Constellation, allowing laboratories to access and use Natera's technology in their own facilities. Constellation is currently only available outside of the United States.
=== Pharmacodynamics === Similarly to ketamine, norketamine acts as a noncompetitive NMDA receptor antagonist (Ki = 1.7 μM and 13 μM for (S)-(+)-norketamine and (R)-(–)-norketamine, respectively). Also, similarly again to ketamine, norketamine binds to the μ- and κ-opioid receptors. Relative to ketamine, norketamine is much more potent as an antagonist of the α7-nicotinic acetylcholine receptor, and produces rapid antidepressant effects in animal models which have been reported to correlate with its activity at this receptor. However, norketamine is about 1/5 as potent as ketamine as an antidepressant in mice as per the forced swim test, and this seems also to be in accordance with its 3–5-fold reduced comparative potency in vivo as an NMDA receptor antagonist. Norketamine's metabolites, dehydronorketamine (DHNK) and hydroxynorketamine (HNK), are far less or negligibly active as NMDA receptor antagonists in comparison, but retain activity as potent antagonists of the α7-nicotinic acetylcholine receptor. In 2024, norketamine was discovered to act as a highly potent positive allosteric modulator of the opioid receptors, including of the μ-opioid receptor (MOR). It shares this action with ketamine and hydroxynorketamine (HNK). They are all active in this action at very low concentrations, for instance 1 nM. Ketamine, norketamine, and HNK can potentiate the effects of endogenous opioids like met-enkephalin and exogenous opioids like morphine.
Pasteurization is a process for preservation of liquid food. It was originally applied to combat the souring of young local wines. Today, the process is mainly applied to dairy products. In this method, milk is heated at about 70 °C (158 °F) for 15–30 seconds to kill the bacteria present in it and cooling it quickly to 10 °C (50 °F) to prevent the remaining bacteria from growing. The milk is then stored in sterilized bottles or pouches in cold places. This method was invented by Louis Pasteur, a French chemist, in 1862.
Sources: en.wikipedia.org
It is a synthetic peptide built from fifteen amino acids, with a mass of roughly 1419 daltons. The sequence is reported to match a fragment of a protein present in human gastric juice. It is not a naturally circulating hormone.
It is normally supplied as a lyophilized powder in a sealed vial. The powder dissolves readily in water, and stock solutions are typically prepared shortly before use. Cold storage is standard laboratory practice.
The letters are generally read as shorthand for body protection compound. That label comes from the original research context rather than from formal nomenclature. No standardized nonproprietary name exists for the peptide.
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.